India covid-19 vaccine India

Decision on Zydus needle-free Covid vaccine in few days. What you need to know

Reading now: 559
www.livemint.com

Zydus Cadila's application for the emergency use authorization of its Covid-19 vaccine will likely be taken up by a Subject Expert Committee (SEC) of India's drug regulator this week, reported news agency Reuters, citing an Economic Times report.

According to the report, the rolling review of the vaccine has already been conducted. The company had last week submitted an application to the Drugs Controller General of India (DCGI), seeking authorisation for its ZyCoV-D three-dose vaccine.

It also submitted data evaluating a two-dose regimen for the shot. The SEC is now likely to compare the data and make a decision on its go-ahead.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA